Arcturus Therapeutics: Q2 Earnings Snapshot

August 9, 2022 GMT

SAN DIEGO (AP) _ Arcturus Therapeutics (ARCT) on Tuesday reported a loss of $21.6 million in its second quarter.

The San Diego-based company said it had a loss of 82 cents per share.

The results topped Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of $1.84 per share.

The pharmaceutical company posted revenue of $27.1 million in the period, also surpassing Street forecasts. Four analysts surveyed by Zacks expected $3.3 million.

Arcturus Therapeutics shares have decreased 50% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $18.52, a drop of 62% in the last 12 months.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on ARCT at